<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>M/s. Skymap Pharmaceuticals Private Ltd. is approved as Strategic Buyer for disinvestment of Indian Medicines Pharmaceutical Corporation Limited (IMPCL), a CPSE under the administrative control of M/o AYUSH</title>
    <link>https://www.taxtmi.com/news?id=73008</link>
    <description>Strategic disinvestment of Indian Medicines Pharmaceutical Corporation Limited was implemented through a two-stage open competitive bidding process for sale of 100% equity shareholding with transfer of management control. After Expressions of Interest, due diligence, security clearance, and issuance of the Request for Proposal and Share Purchase Agreement, two financial bids were received and evaluated as technically qualified. The highest bidder, M/s. Skymap Pharmaceuticals Private Limited, emerged above the reserve price and was approved as the strategic buyer.</description>
    <language>en-us</language>
    <pubDate>Wed, 27 May 2026 11:10:27 +0530</pubDate>
    <lastBuildDate>Wed, 27 May 2026 11:10:27 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=904061" rel="self" type="application/rss+xml"/>
    <item>
      <title>M/s. Skymap Pharmaceuticals Private Ltd. is approved as Strategic Buyer for disinvestment of Indian Medicines Pharmaceutical Corporation Limited (IMPCL), a CPSE under the administrative control of M/o AYUSH</title>
      <link>https://www.taxtmi.com/news?id=73008</link>
      <description>Strategic disinvestment of Indian Medicines Pharmaceutical Corporation Limited was implemented through a two-stage open competitive bidding process for sale of 100% equity shareholding with transfer of management control. After Expressions of Interest, due diligence, security clearance, and issuance of the Request for Proposal and Share Purchase Agreement, two financial bids were received and evaluated as technically qualified. The highest bidder, M/s. Skymap Pharmaceuticals Private Limited, emerged above the reserve price and was approved as the strategic buyer.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Wed, 27 May 2026 11:10:27 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=73008</guid>
    </item>
  </channel>
</rss>